CARRIE SCHWIER: Open Payments
NPI 1386686335 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,302 in 63 payments from 12 companies in 2025. Trend: 2023 $1,040 · 2024 $1,239 · 2025 $1,302
Food & beverage: $1,302
| Company | Payments | Amount |
|---|---|---|
| ABIOMED | 8 | $332 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 13 | $248 |
| E.R. Squibb & Sons, L.L.C. | 9 | $180 |
| Novartis Pharmaceuticals Corporation | 14 | $164 |
| Novo Nordisk Inc | 3 | $70 |
| Merck Sharp & Dohme LLC | 4 | $66 |
| PFIZER INC. | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $47 |
| Kestra Medical Technology Services, Inc. | 1 | $29 |
Products named: LifeVest, LEQVIO, ELIQUIS, CAMZYOS, Kerendia, VERQUVO, Ozempic, JARDIANCE.
Industry payments across OK — which companies pay providers there.
